FDA drug information that never reaches clinicians.
John
J
Hohneker
Solveig
S
Ericson
Gabriela
G
Gruia
D004164:Diphosphonates / Q000008:administration & dosage* / Q000009:adverse effects; D017277:Drug Approval; D004345:Drug Industry; D004348:Drug Labeling; D006801:Humans; D006934:Hypercalcemia / Q000188:drug therapy; D007093:Imidazoles / Q000008:administration & dosage* / Q000009:adverse effects; D007674:Kidney Diseases / Q000139:chemically induced / Q000401:mortality; D014481:United States; D014486:United States Food and Drug Administration; D000077211:Zoledronic Acid
D004164:Diphosphonates; D007093:Imidazoles; D000077211:Zoledronic Acid